Clinical Trial Update: Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluated the pharmacokinetics of somatropin in patients with end-stage renal disease on chronic haemodialysis. The study provides …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Chronic Kidney Disease, End-Stage Renal Disease | Phase 1 | Status: COMPLETED